Evidence map›Paper›PMID 22430960›Full record

ArticleAntimicrobial agents and chemotherapy2012

A potent plant-derived antifungal acetylenic acid mediates its activity by interfering with fatty acid homeostasis.

Tao Xu, Siddharth K Tripathi, Qin Feng, Michael C Lorenz, Marsha A Wright, Melissa R Jacob, Melanie M Mask, Scott R Baerson, Xing-Cong Li, Alice M Clark and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Phylogenetic Aspects of Higher Plant Lipid Fatty Acid Profile.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Tao XuNational Center for Natural Products Research, University of Mississippi, University, Mississippi, USA.
Siddharth K Tripathi
Qin Feng
Michael C Lorenz
Marsha A Wright
Melissa R Jacob
Melanie M Mask
Scott R Baerson
Xing-Cong Li
Alice M Clark
Ameeta K Agarwal
University of Mississippi · USAgricultural Research Service · USThe University of Texas Health Science Center at Houston · USUnited States Department of Agriculture · US

Funding

NEW DRUGS FOR OPPORTUNISTIC INFECTIOUS DISEASESR01AI027094 · NIAID · UNIVERSITY OF MISSISSIPPI · PI CLARK, ALICE M. · 1989 to 2013
$4.4M
Molecular Targets of Novel Antifungal CompoundsR21AI067873 · NIAID · UNIVERSITY OF MISSISSIPPI · PI AGARWAL, AMEETA KISHORE · 2007 to 2008
$405k
NIAID NIH HHS R01 AI027094NIAID NIH HHS R01AI27094NIAID NIH HHS R21 AI067873NIAID NIH HHS R21 AI67873
6 · The paper itself

Abstract

6-Nonadecynoic acid (6-NDA), a plant-derived acetylenic acid, exhibits strong inhibitory activity against the human fungal pathogens Candida albicans, Aspergillus fumigatus, and Trichophyton mentagrophytes. In the present study, transcriptional profiling coupled with mutant and biochemical analyses were conducted using the model yeast Saccharomyces cerevisiae to investigate its mechanism of action. 6-NDA elicited a transcriptome response indicative of fatty acid stress, altering the expression of genes that are required for yeast growth in the presence of oleate. Mutants of S. cerevisiae lacking transcription factors that regulate fatty acid β-oxidation showed increased sensitivity to 6-NDA. Fatty acid profile analysis indicated that 6-NDA inhibited the formation of fatty acids longer than 14 carbons in length. In addition, the growth inhibitory effect of 6-NDA was rescued in the presence of exogenously supplied oleate. To investigate the response of a pathogenic fungal species to 6-NDA, transcriptional profiling and biochemical analyses were also conducted in C. albicans. The transcriptional response and fatty acid profile of C. albicans were comparable to those obtained in S. cerevisiae, and the rescue of growth inhibition with exogenous oleate was also observed in C. albicans. In a fluconazole-resistant clinical isolate of C. albicans, a fungicidal effect was produced when fluconazole was combined with 6-NDA. In hyphal growth assays, 6-NDA inhibited the formation of long hyphal filaments in C. albicans. Collectively, our results indicate that the antifungal activity of 6-NDA is mediated by a disruption in fatty acid homeostasis and that 6-NDA has potential utility in the treatment of superficial Candida infections.

Indexed as

AlkynesAntifungal AgentsCandida albicansFatty AcidsFatty Acids, MonounsaturatedFatty Acids, UnsaturatedFluconazoleSaccharomyces cerevisiae2-hexadecynoic acid6-nonadecynoic acidAlkynesAntifungal AgentsFatty AcidsFatty Acids, MonounsaturatedFatty Acids, UnsaturatedFluconazole

Identifiers

PMID22430960
PMCPMC3370752
OpenAlexW2137676612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.